Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Other financing activities: 2015-2024

Historic Other financing activities for Mimedx Group (MDXG) over the last 7 years, with Dec 2024 value amounting to $1.1 million.

  • Mimedx Group's Other financing activities was N/A to $1.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 2217.31% up from last year.
  • Mimedx Group's Other financing activities amounted to $1.1 million in FY2024, which was up 2,217.31% from -$52,000 recorded in FY2023.
  • Mimedx Group's Other financing activities' 5-year high stood at $7.5 million during FY2020, with a 5-year trough of -$52,000 in FY2023.
  • In the last 3 years, Mimedx Group's Other financing activities had a median value of -$41,000 in 2022 and averaged $336,000.
  • As far as peak fluctuations go, Mimedx Group's Other financing activities declined by 26.83% in 2023, and later spiked by 2,217.31% in 2024.
  • Mimedx Group's Other financing activities (Yearly) stood at $7.5 million in 2020, then reached -$41,000 in 2022, then declined by 26.83% to -$52,000 in 2023, then skyrocketed by 2,217.31% to $1.1 million in 2024.